Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVX | Common Stock | Options Exercise | $2.59M | +25K | +312500% | $103.71 | 25K | Nov 28, 2022 | Direct | F1 |
transaction | CVX | Common Stock | Sale | -$1.26M | -7.08K | -28.3% | $178.62 | 17.9K | Nov 28, 2022 | Direct | F1, F2 |
transaction | CVX | Common Stock | Sale | -$1.97M | -11K | -61.17% | $179.65 | 6.96K | Nov 28, 2022 | Direct | F1, F3 |
transaction | CVX | Common Stock | Sale | -$1.24M | -6.85K | -98.45% | $180.64 | 108 | Nov 28, 2022 | Direct | F1, F4 |
transaction | CVX | Common Stock | Sale | -$18.1K | -100 | -92.59% | $181.25 | 8 | Nov 28, 2022 | Direct | F1 |
holding | CVX | Common Stock | 19.1K | Nov 28, 2022 | by 401(k) plan | ||||||
holding | CVX | Common Stock | 28.3K | Nov 28, 2022 | by Breber Family Trust |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVX | Non-Qualified Stock Option (Right to Buy) | Options Exercise | $0 | -25K | -40.78% | $0.00 | 36.3K | Nov 28, 2022 | Common Stock | 25K | $103.71 | Direct | F5 |
Id | Content |
---|---|
F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2022. |
F2 | These shares were sold in multiple transactions at prices ranging from $178.10 to $179.06, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. |
F3 | These shares were sold in multiple transactions at prices ranging from $179.11 to $180.10, inclusive. The price reported in Column 4 reflects the weighted average sale price. |
F4 | These shares were sold in multiple transactions at prices ranging from $180.12 to $181.11, inclusive. The price reported in Column 4 reflects the weighted average sale price. |
F5 | Option granted 1/28/2015. One-third of the shares subject to the option vested on each of the first, second and third anniversaries of the date of grant. |